Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
In Re: Cardinal Health, Inc. Derivative Litigation
Case Number:
2:19-cv-02491
Court:
Nature of Suit:
Multi Party Litigation:
Derivative Litigation
Judge:
Firms
- Baker & Hostetler
- Elsberg Baker
- Gardy & Notis
- Kessler Topaz
- Organ Law LLP
- Porter Wright
- Strauss Troy
- Wachtell Lipton
Companies
Sectors & Industries:
-
October 07, 2022
Cardinal Health, Investors Get Final OK To $124M Deal
An Ohio federal judge on Friday gave her final approval to a $124 million deal Cardinal Health Inc.'s directors and investors reached to settle a shareholder derivative suit alleging the directors failed to protect the health care services company from liability in the wake of the opioid crisis.
-
May 26, 2022
Cardinal Investors Reach $124M Settlement In Opioid Suit
Directors of Cardinal Health Inc. and the company's investors have reached a $124 million settlement resolving claims of a shareholder derivative suit that the directors failed to protect the company from liability in the opioid crisis.
-
February 08, 2021
Claim Clipped From Cardinal Investors' Suit Over Opioids
An Ohio federal judge on Monday cut in half an investors' suit alleging the directors of Cardinal Health Inc. failed to protect the company from liability in the opioid crisis, allowing claims that the directors turned a blind eye to red flags, but tossing out claims they overpaid themselves at the same time.
-
September 24, 2019
Cardinal Health Board Wants Opioid Derivative Suit Axed
The board of directors of pharmaceutical distributor Cardinal Health Inc. has urged an Ohio federal judge to toss an activist shareholder's derivative suit related to the opioid crisis, saying it was similar to suits that have already been discarded in two Ohio courts, one federal and one state.